Gretex Corporate Services Limited (BOM:543324)

Sage Therapeutics Income Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Total Interest Expense	5.57	1.76	2.03	2.42	2.91
Net Interest Income	-5.57	-1.76	-2.03	-2.42	-2.91
Gain on Sale of Investments (Rev)	29.2	73.82	14.01	1.83	1.5
Other Revenue	2,605	1,093	139.52	44.55	29.84
Revenue	2,629	1,165	151.5	43.96	28.42
Revenue Growth (YoY)	125.66%	668.94%	244.61%	54.67%	226.30%
Salaries & Employee Benefits	113.43	51.03	15.02	6.97	5.84
Cost of Services Provided	2,284	531.82	6.38	7.54	2.55
Other Operating Expenses	176.96	101.8	32.37	12.19	12.01
Total Operating Expenses	2,601	700.6	58.36	28.37	21.93
Operating Income	27.85	464.36	93.14	15.59	6.49
Other Non-Operating Income (Expenses)	20.23	0.19	0.34	0.1	0.07
EBT Excluding Unusual Items	48.07	478.72	238.62	36.2	6.56
Other Unusual Items	2.3	-9.02	-0.66	0.03	0.91
Pretax Income	50.37	471.39	238.13	36.23	7.47
Income Tax Expense	32.22	104.98	20.49	0.49	0.25
Earnings From Continuing Ops.	18.15	366.41	217.64	35.75	7.22
Minority Interest in Earnings	-	-	-3.47	-	-
Net Income	18.15	366.41	214.17	35.75	7.22
Net Income to Common	18.15	366.41	214.17	35.75	7.22
Net Income Growth	-95.05%	71.08%	499.14%	394.85%	-
Shares Outstanding (Basic)	31	29	19	19	14
Shares Outstanding (Diluted)	32	29	19	19	14
Shares Change (YoY)	10.81%	47.77%	0.78%	36.48%	26.24%
EPS (Basic)	0.58	12.75	11.01	1.85	0.51
EPS (Diluted)	0.57	12.75	11.01	1.85	0.51
EPS Growth	-95.53%	15.80%	494.42%	262.58%	-
Free Cash Flow	-346.06	-397	94.98	15.86	4.98
Free Cash Flow Per Share	-10.87	-13.81	4.88	0.82	0.35
Dividend Per Share	0.316	0.316	0.263	-	-
Dividend Growth	-	19.98%	-	-	-
Operating Margin	1.06%	39.86%	61.48%	35.47%	22.85%
Profit Margin	0.69%	31.45%	141.37%	81.31%	25.41%
Free Cash Flow Margin	-13.16%	-34.08%	62.69%	36.08%	17.54%
Effective Tax Rate	63.97%	22.27%	8.61%	1.34%	3.34%
Revenue as Reported	2,657	1,178	154.03	47.45	32.46

Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Capital Markets template. Financial Sources.